172 related articles for article (PubMed ID: 21396314)
1. Imaged guided transarterial chemoembolization with drug-eluting beads loaded with doxorubicin (DEBDOX) for hepatic metastases from melanoma: early outcomes from a multi-institutional registry.
Brown RE; Gibler KM; Metzger T; Trofimov I; Krebs H; Romero FD; Scoggins CR; McMasters KM; Martin RC
Am Surg; 2011 Jan; 77(1):93-8. PubMed ID: 21396314
[TBL] [Abstract][Full Text] [Related]
2. Optimal outcomes for liver-dominant metastatic breast cancer with transarterial chemoembolization with drug-eluting beads loaded with doxorubicin.
Martin RC; Robbins K; Fagés JF; Romero FD; Rustein L; Tomalty D; Monaco R
Breast Cancer Res Treat; 2012 Apr; 132(2):753-63. PubMed ID: 22200868
[TBL] [Abstract][Full Text] [Related]
3. Image-Guided Transarterial Chemoembolization With Drug-Eluting Beads Loaded with Doxorubicin (DEBDOX) for Unresectable Hepatic Metastases from Melanoma: Technique and Outcomes.
Rostas J; Tam A; Sato T; Kelly L; Tatum C; Scoggins C; McMasters K; Martin RCG
Cardiovasc Intervent Radiol; 2017 Sep; 40(9):1392-1400. PubMed ID: 28508253
[TBL] [Abstract][Full Text] [Related]
4. Hepatic arterial infusion of doxorubicin-loaded microsphere for treatment of hepatocellular cancer: a multi-institutional registry.
Martin RC; Rustein L; Pérez Enguix D; Palmero J; Carvalheiro V; Urbano J; Valdata A; Kralj I; Bosnjakovic P; Tatum C
J Am Coll Surg; 2011 Oct; 213(4):493-500. PubMed ID: 21856182
[TBL] [Abstract][Full Text] [Related]
5. Transarterial chemoembolization of liver metastases from well differentiated gastroenteropancreatic endocrine tumors with doxorubicin-eluting beads: preliminary results.
de Baere T; Deschamps F; Teriitheau C; Rao P; Conengrapht K; Schlumberger M; Leboulleux S; Baudin E; Hechellhammer L
J Vasc Interv Radiol; 2008 Jun; 19(6):855-61. PubMed ID: 18503899
[TBL] [Abstract][Full Text] [Related]
6. Health-related quality of life during trans-arterial chemoembolization with drug-eluting beads loaded with doxorubicin (DEBDOX) for unresectable hepatic metastases from ocular melanoma.
Rostas JW; Tam AL; Sato T; Scoggins CR; McMasters KM; Martin RCG
Am J Surg; 2017 Nov; 214(5):884-890. PubMed ID: 28754534
[TBL] [Abstract][Full Text] [Related]
7. Chemoembolization with drug eluting beads preloaded with irinotecan (DEBIRI) vs doxorubicin (DEBDOX) as a second line treatment for liver metastases from cholangiocarcinoma: a preliminary study.
Venturini M; Sallemi C; Agostini G; Marra P; Cereda S; Reni M; Aldrighetti L; De Cobelli F; Del Maschio A
Br J Radiol; 2016 Nov; 89(1067):20160247. PubMed ID: 27558984
[TBL] [Abstract][Full Text] [Related]
8. Transarterial chemoembolization of unresectable hepatocellular carcinoma with drug eluting beads: results of an open-label study of 62 patients.
Malagari K; Chatzimichael K; Alexopoulou E; Kelekis A; Hall B; Dourakis S; Delis S; Gouliamos A; Kelekis D
Cardiovasc Intervent Radiol; 2008; 31(2):269-80. PubMed ID: 17999110
[TBL] [Abstract][Full Text] [Related]
9. Management of diffuse hepatocellular carcinoma (≧ 10 Lesions) with doxorubicin-loaded DC beads is a safe and effective treatment option.
Cannon RM; Urbano J; Kralj I; Bosnjakovic P; Martin RC
Onkologie; 2012; 35(4):184-8. PubMed ID: 22488088
[TBL] [Abstract][Full Text] [Related]
10. Treatment of melanoma metastases confined to the liver and future perspectives.
Vahrmeijer AL; van de Velde CJ; Hartgrink HH; Tollenaar RA
Dig Surg; 2008; 25(6):467-72. PubMed ID: 19212119
[TBL] [Abstract][Full Text] [Related]
11. Response, survival, and prognostic factors after hepatic arterial chemoembolization in patients with liver metastases from cutaneous melanoma.
Ahrar J; Gupta S; Ensor J; Ahrar K; Madoff DC; Wallace MJ; Murthy R; Tam A; Hwu P; Bedikian AY
Cancer Invest; 2011 Jan; 29(1):49-55. PubMed ID: 21166498
[TBL] [Abstract][Full Text] [Related]
12. Intraprocedural 3D perfusion measurement during chemoembolisation with doxorubicin-eluting beads in liver metastases of malignant melanoma.
Pereira PL; Krüger K; Hohenstein E; Welke F; Sommer C; Meier F; Eigentler T; Garbe C
Eur Radiol; 2018 Apr; 28(4):1456-1464. PubMed ID: 29124381
[TBL] [Abstract][Full Text] [Related]
13. A phase I/II trial of chemoembolization for hepatocellular carcinoma using a novel intra-arterial drug-eluting bead.
Poon RT; Tso WK; Pang RW; Ng KK; Woo R; Tai KS; Fan ST
Clin Gastroenterol Hepatol; 2007 Sep; 5(9):1100-8. PubMed ID: 17627902
[TBL] [Abstract][Full Text] [Related]
14. Comparison of conventional transarterial chemoembolization (TACE) and chemoembolization with doxorubicin drug eluting beads (DEB) for unresectable hepatocelluar carcinoma (HCC).
Dhanasekaran R; Kooby DA; Staley CA; Kauh JS; Khanna V; Kim HS
J Surg Oncol; 2010 May; 101(6):476-80. PubMed ID: 20213741
[TBL] [Abstract][Full Text] [Related]
15. Chemoembolization of hepatocellular carcinoma with drug eluting beads: efficacy and doxorubicin pharmacokinetics.
Varela M; Real MI; Burrel M; Forner A; Sala M; Brunet M; Ayuso C; Castells L; Montañá X; Llovet JM; Bruix J
J Hepatol; 2007 Mar; 46(3):474-81. PubMed ID: 17239480
[TBL] [Abstract][Full Text] [Related]
16. Safety profile of sequential transcatheter chemoembolization with DC Bead™: results of 237 hepatocellular carcinoma (HCC) patients.
Malagari K; Pomoni M; Spyridopoulos TN; Moschouris H; Kelekis A; Dourakis S; Alexopoulou E; Koskinas J; Angelopoulos M; Kornezos J; Pomoni A; Tandeles S; Marinis A; Rizos S; Kelekis D
Cardiovasc Intervent Radiol; 2011 Aug; 34(4):774-85. PubMed ID: 21184228
[TBL] [Abstract][Full Text] [Related]
17. Drug-loaded microspheres for the treatment of liver cancer: review of current results.
Kettenbach J; Stadler A; Katzler IV; Schernthaner R; Blum M; Lammer J; Rand T
Cardiovasc Intervent Radiol; 2008; 31(3):468-76. PubMed ID: 18228095
[TBL] [Abstract][Full Text] [Related]
18. Transarterial chemoembolization of liver metastases from uveal melanoma after failure of systemic therapy: toxicity and outcome.
Schuster R; Lindner M; Wacker F; Krössin M; Bechrakis N; Foerster MH; Thiel E; Keilholz U; Schmittel A
Melanoma Res; 2010 Jun; 20(3):191-6. PubMed ID: 20335820
[TBL] [Abstract][Full Text] [Related]
19. Radioembolization Versus Chemoembolization (DEBDOX) for the Treatment of Unresectable Hepatocellular Carcinoma: A Propensity Matched Study.
Akinwande O; Philips P; Scoggins C; Martin RC
Anticancer Res; 2016 Jan; 36(1):239-46. PubMed ID: 26722049
[TBL] [Abstract][Full Text] [Related]
20. Toxicity of irinotecan-eluting beads in the treatment of hepatic malignancies: results of a multi-institutional registry.
Martin RC; Howard J; Tomalty D; Robbins K; Padr R; Bosnjakovic PM; Tatum C
Cardiovasc Intervent Radiol; 2010 Oct; 33(5):960-6. PubMed ID: 20661569
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
